Susquehanna International Group, LLP Virios Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 65,991 shares of VIRI stock, worth $12,538. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,991
Previous 23,363
182.46%
Holding current value
$12,538
Previous $11,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIRI
# of Institutions
27Shares Held
991KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$39,6870.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$33,1490.0% of portfolio
-
Ubs Group Ag152KShares$28,8380.0% of portfolio
-
Hrt Financial LP New York, NY57.5KShares$10,9330.0% of portfolio
-
Mc Collum Christoferson Group LLC Amherst, NY57KShares$10,8300.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $3.48M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...